Results 191 to 200 of about 878,930 (205)

Treating high density lipoprotein cholesterol (HDL-C): quantity versus quality.

Current pharmaceutical design, 2013
Low density lipoproteins (LDL) and high density lipoproteins (HDL) are independent risk factors for coronary heart disease (CHD); decreasing LDL-cholesterol (LDL-C) levels with statin therapy represents the primary goal in the management of ...
A. Pirillo, G. Norata, A. Catapano
semanticscholar   +1 more source

Total Cholesterol, HDL-Cholesterol, and Risk of Nosocomial Infection: A Prospective Study in Surgical Patients

Infection Control & Hospital Epidemiology, 1997
Objective: To study the relationship between serum high-density lipoprotein cholesterol (HDL-C), total serum cholesterol, and nosocomial infection in patients undergoing general surgery.
M. Delgado-Rodríguez   +3 more
semanticscholar   +2 more sources

Risk of nosocomial infections and effects of total cholesterol, HDL cholesterol in surgical patients.

Clinical Nutrition, 2002
BACKGROUND AND AIMS Changes of lipoprotein pattern in plasma occur in many acute infections. The aim of this study was to analyse the role of total cholesterol and HDL cholesterol in postsurgical patients with nosocomial infection. METHODS Four hundred
N. Z. Cantürk   +4 more
semanticscholar   +1 more source

Cholesterol, high density lipoprotein-cholesterol (HDL) and cholesterol/HDL-ratio versus arterial blood pressure.

Acta medica Scandinavica. Supplementum, 2009
In a cardiovascular survey of 928 men and women aged exactly 30, 40, 50 & 60 years, a correlation between serum cholesterol, cholesterol/HDL-ratio and arterial blood pressure was found.
E. Agner   +5 more
semanticscholar   +1 more source

Monocyte‐to‐HDL‐cholesterol ratio as a prognostic marker in cardiovascular diseases

Journal of Cellular Physiology, 2018
Inflammation and lipid accumulation are two basic hallmarks of atherosclerosis as a chronic disease. Inflammation not only is a local response but can also be considered as a systemic process followed by an elevation of inflammatory mediators.
S. Ganjali   +6 more
semanticscholar   +1 more source

From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants

Current Opinion in Lipidology, 2019
Purpose of review The validity of HDL-cholesterol (HDL-C) elevation as a therapeutic target has been questioned, in comparison to enhancing HDL functionality.
D. Rhainds, J. Tardif
semanticscholar   +1 more source

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1.

International Journal of Cardiology, 2013
Se Won Kim   +12 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy